The new blood thinner Pradaxa has been linked to an increased risk of serious and potentially life-threatening bleeding, leading many to question its safety. PRADAXA LAWSUIT STATUS: In May 2014, Boehringer Ingelheim and attorneys for plaintiffs reached a Pradaxa settlement agreement for $650 million, which would resolve about 4,000 Pradaxa bleeding lawsuits.…
The blood thinner Xarelto is linked to severe and potentially deadly bleeding events. Product liability lawyers are investigating potential Xarelto lawsuits.…
A new study indicates Xarelto carries greater risks of bleeding events and death for recent heart valve replacement patients.…
The FDA is warning consumers not to use pre-owned test strips for monitoring glucose or blood thinners, due to a number of potential risks.…
A proposed $775 million settlement agreement could resolve nearly all outstanding Xarelto bleeding injury lawsuits.…
A new study finds that while Eliquis could prevent dangerous blood clots in cancer patients, it also doubles their risk of suffering major bleeding events.…
A new study found that Xarelto failed to prevent deaths from heart disease and heart failure.…
A new study finds that Xarelto appears to be relatively ineffective in preventing blood clot-related problems in recently hospitalized patients.…
A hearing today will determine whether an appeals court could hear arguments indicating that Xarelto lawsuits are preempted by federal law.…
A jury in Pennsylvania issued a defense verdict in the latest Xarelto bleeding injury lawsuit to go to trial.…
